About camp4 therapeutics corp - CAMP
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
CAMP At a Glance
CAMP4 Therapeutics Corp.
1 Kendall Square
Cambridge, Massachusetts 02139
| Phone | 1-617-651-8867 | Revenue | 3.50M | |
| Industry | Biotechnology | Net Income | -80,403,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 436.503% | |
| Fiscal Year-end | 12 / 2026 | Employees | 48 | |
| View SEC Filings |
CAMP Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 53.24 |
| Price to Book Ratio | 6.67 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.534 |
| Enterprise Value to Sales | 22.111 |
| Total Debt to Enterprise Value | 0.026 |
CAMP Efficiency
| Revenue/Employee | 72,875.00 |
| Income Per Employee | -1,675,062.50 |
| Receivables Turnover | 22.568 |
| Total Asset Turnover | 0.036 |
CAMP Liquidity
| Current Ratio | 7.354 |
| Quick Ratio | 7.354 |
| Cash Ratio | 7.146 |
CAMP Profitability
| Gross Margin | 53.145 |
| Operating Margin | -1,488.308 |
| Pretax Margin | -2,298.542 |
| Net Margin | -2,298.542 |
| Return on Assets | -81.996 |
| Return on Equity | -145.069 |
| Return on Total Capital | -161.848 |
| Return on Invested Capital | -136.162 |
CAMP Capital Structure
| Total Debt to Total Equity | 4.138 |
| Total Debt to Total Capital | 3.974 |
| Total Debt to Total Assets | 1.676 |
| Long-Term Debt to Equity | 3.538 |
| Long-Term Debt to Total Capital | 3.398 |